Financings for May 26, 2026

FierceBiotechMakary’s FDA reforms ‘continue to move forward’ despite leadership turmoil

Endpoints NewsCartesian secures funding to 'accelerate' launch; Editas sells $125M in stock

Endpoints NewsCan AI do scientific research? Billions chase hopes of superintelligence

BioWorldBiggest gainers and losers for May 18-22, 2026

FierceBiotechKura posts Krazati combo data on drug designed to unleash KRAS inhibitors’ potential

BioPharma DiveAstellas eyes more cost cuts; FDA panel to debate Moderna vaccine

Thermo FisherThermo Fisher (TMO) Is More Than a Biotech Funding Proxy - AlphaStreet

Endpoints NewsExclusive: Protuoso gets $9.5M to build the next hub-and-spoke antibody developer

PharmaVoiceCan a chaotic FDA still deliver on faster drug development?

BioWorldMSD divulges new KLKB1 inhibitors

BioWorldKunshan Xinyunda Biotechnology synthesizes new ADAM9-targeting ADCs

BioWorldConvalife Pharmaceuticals discloses new CD38 inhibitors